欧洲滴眼液市场预测至 2030 年 – 区域分析 – 按类型（抗生素、人工泪液、激素等）、应用{眼部疾病（干眼、青光眼、白内障等）、眼部护理等}，以及购买模式（非处方药和处方药）
No. of Pages: 99 | Report Code: BMIRE00029073 | Category: Life Sciences
No. of Pages: 99 | Report Code: BMIRE00029073 | Category: Life Sciences
欧洲滴眼液市场分为德国、英国、法国、意大利、西班牙和欧洲其他地区。该地区在欧洲滴眼剂市场中占有重要份额。该地区的市场增长归因于欧洲国家各种国内参与者的不断增加以及干眼病患病率的不断上升。德国有许多人患有眼部疾病。此外，该国老年人群中干眼症的发病率正在增加。青光眼是导致大众干眼症的另一个主要因素。德国记录了青光眼、白内障和视网膜脱离等眼科疾病的广泛发生。根据2021年5月发表在《眼科杂志》上的文章《德国视网膜脱离的发生率：古腾堡健康研究的结果》，德国视网膜脱离疾病的发病率为每年每10万人中42人35&nd;74 岁。与其他欧洲国家的估计相比，该研究预计德国该年龄段的视网膜脱离发生率较高。
根据联邦统计局 (Destatis) 的数据，~截至 2021 年底，德国 67 岁及以上人口为 1620 万人，预计到 2060 年这一数字将增至 2160 万人。此外，疾病和视力问题在老年人中更为常见。未来几年，随着德国人口老龄化的加剧，与眼部相关疾病的发病率预计将增加，从而推动该国欧洲滴眼液市场的增长。
欧洲眼药水市场细分
欧洲眼药水市场细分为类型、应用、购买模式和
根据类型，欧洲滴眼剂市场分为抗生素、人工泪液、激素等。 2022年，抗生素细分市场在欧洲滴眼液市场中占据最大份额。
根据应用，欧洲滴眼液市场分为眼部疾病、眼部护理、和别的。到 2022 年，眼病细分市场在欧洲滴眼液市场中占据最大份额。眼病细分市场进一步细分为干眼症、青光眼、白内障等。
基于从购买模式上看，欧洲滴眼液市场分为OTC和处方药。 2022 年，处方药在欧洲滴眼液市场中占据较大份额。
根据国家/地区，欧洲滴眼液市场分为德国、英国、法国、意大利、西班牙和欧洲其他国家。 2022 年，德国在欧洲滴眼液市场占据主导地位。
AbbVie Inc、Akorn Operating Company LLC、Alcon AG、Bausch & Co. Lomb Inc、辉瑞公司、Prestige Consumer Healthcare Inc.、乐敦制药有限公司、Sager Pharma Kft. 和 Similasan Corp 是欧洲滴眼剂市场上的一些领先公司。
Strategic insights for Europe Eye Drops involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2022 | US$ 3,496.63 Million |
| Market Size by 2030 | US$ 5,093.11 Million |
| Global CAGR (2022 - 2030) | 4.8% |
| Historical Data | 2020-2021 |
| Forecast period | 2023-2030 |
| Segments Covered |
By 类型
|
| Regions and Countries Covered | 欧洲
|
| Market leaders and key company profiles |
The regional scope of Europe Eye Drops refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Europe Eye Drops Market is valued at US$ 3,496.63 Million in 2022, it is projected to reach US$ 5,093.11 Million by 2030.
As per our report Europe Eye Drops Market, the market size is valued at US$ 3,496.63 Million in 2022, projecting it to reach US$ 5,093.11 Million by 2030. This translates to a CAGR of approximately 4.8% during the forecast period.
The Europe Eye Drops Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Eye Drops Market report:
The Europe Eye Drops Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Eye Drops Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Eye Drops Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Eye Drops Market
